Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd Share Price (AJANTPHARM)

Check the latest share price of Ajanta Pharma Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹2695.52.43%

as on 04:01PM, 04 Jul 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Ajanta Pharma Ltd Stock Performance

Get live Ajanta Pharma Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹2,623.2
    Day's Price Range
    ₹2,710
  • 52 Week's Low

    52 Week's High

    ₹2,160.15
    52-Week Price Range
    ₹3,485
1 Month Return+ 4.57 %
3 Month Return+ 13.52 %
1 Year Return+ 18.92 %
3 Year Return+ 120.98 %
5 Year Return+ 187.13 %
Previous Close₹2,631.50
Open₹2,645.00
Volume2.41L
Upper Circuit₹3,157.80
Lower Circuit₹2,105.20

Ajanta Pharma Ltd Fundamentals & Key Indicators

Check Ajanta Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹33,670.06 Cr

Return on Equity (ROE)

26.05

PE Ratio (TTM)

36.72

Return on capital employed (ROCE)

32.78

Industry PE ratio

54.65

Beta (LTM)

0.67

P/B Ratio

9.05

Dividend Yield

1.07

PEG Ratio

4.27

Quarterly Earnings Growth YOY

11.12

EPS (TTM)

73.43

Sector

Pharmaceuticals

Book Value

302.38

Technical Analysis

How to invest in Ajanta Pharma Ltd?

Investing in Ajanta Pharma Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Ajanta Pharma Ltd or AJANTPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Ajanta Pharma Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Ajanta Pharma Ltd with just a few clicks!

Ajanta Pharma Ltd Stock's Interest Amongst Investors

53%

Period Jul 06, 2025 to Jun 06, 2025. Change in 30 Days vs previous period

Search interest for Ajanta Pharma Ltd Stock has increased by 53% in the last 30 days, reflecting an upward trend in search activity.

Ajanta Pharma Ltd Valuation

Track how Ajanta Pharma Ltd P/E has moved over time to understand its valuation trends.

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (36.72x)

July 4, 2025

Industry (54.65x)

July 4, 2025

Highest (50.52x)

September 10, 2024

LowHigh

Today’s Price to Earnings Ratio: 36.72x

Ajanta Pharma Ltd Stock Recommendation

Get updated buy, sell, and hold recommendations by analysts on Ajanta Pharma Ltd.

based on 12 analysts

BUY

66.67%

Buy

8.33%

Hold

25.00%

Sell

66.67% of analysts recommend a 'BUY' rating for Ajanta Pharma Ltd. Average target price of ₹2980

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Share Price Target

Get share price movements and forecasts by analysts on Ajanta Pharma Ltd.

Ajanta Pharma Ltd price forecast by 12 analysts

Upside of10.55%

High

₹3293

Target

₹2980.00

Low

₹2288

Ajanta Pharma Ltd target price ₹2980, a slight upside of 10.55% compared to current price of ₹2695.5. According to 12 analysts rating.

Source: S&P Global Market Intelligence

Ajanta Pharma Ltd Financial Results

Get the annual and quarterly financial summary of Ajanta Pharma Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

1054 (0%)1145 (9%)1187 (4%)1146 (3%)1170 (2%)
Net Income

(in ₹ Cr)

203 (0%)246 (21%)216 (12%)233 (8%)225 (3%)
Net Profit Margin19.23% (0%)21.47% (12%)18.24% (15%)20.32% (11%)19.25% (5%)
Value in ₹ crore
DetailsFY22FY23FY24FY25
Total Assets

(in ₹ Cr)

3809 (0%)4339 (14%)4252 (2%)4592 (8%)
Total Liabilities

(in ₹ Cr)

639 (0%)1093 (71%)839 (23%)966 (15%)
Value in ₹ crore
DetailsFY21FY22FY23FY24FY25
Operating Cash Flow

(in ₹ Cr)

467 (0%)542 (16%)736 (36%)735 (0%)1054 (43%)

Indices Featuring Ajanta Pharma Ltd Stock

Check stock indices that include Ajanta Pharma Ltd.

S&P BSE 250 LargeMidCap

₹10,965.76

0.23 (25.08%)

BSE Mid-Cap

₹46,814.34

0.23 (106.01%)

BSE Healthcare

₹44,895.66

0.64 (287.55%)

Nifty 500

₹23,562.45

0.17 (40.6%)

NIFTY PHARMA

₹22,384.60

0.81 (180.35%)

Nifty MidSmallcap 400

₹20,482.05

0 (-0.75%)

Nifty Midcap 150

₹21,973.15

-0.02 (-4.1%)

S&P BSE 400 MidSmallCap

₹12,342.35

0.17 (20.5%)

S&P BSE 150 MidCap

₹16,307.28

0.25 (41.36%)

Nifty LargeMidcap 250

₹16,543.35

0.11 (18.6%)

BSE 500

₹36,967.25

0.21 (76.28%)

Ajanta Pharma Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Ajanta Pharma Ltd.

  • Ajanta Pharma Ltd Earnings Results

    Ajanta Pharma Ltd’s net profit jumped 11.12% since last year same period to ₹225.26Cr in the Q4 2024-2025. On a quarterly growth basis, Ajanta Pharma Ltd has generated -3.27% fall in its net profits since last 3-months.

    Read More about Earnings Results
  • Ajanta Pharma Ltd Dividends October,2024

    In the quarter ending September 2024, Ajanta Pharma Ltd has declared dividend of ₹28 - translating a dividend yield of 2%.

    Read More about Dividends

Ajanta Pharma Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Ajanta Pharma Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
66.26%
0.00
Foreign Institutions
8.86%
0.00
Mutual Funds
15.13%
0.00
Retail Investors
7.39%
0.00
Others
2.36%
0.00

Ajanta Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Ajanta Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
BUY33,670.0637.43%0.529204,648
BUY14,004.54-3.99%0.524132,013
BUY69,802.8711.03%0.563,16829,001
HOLD1,00,724.0235.17%0.643,85419,547
BUY73,811.8824.18%0.53NANA

Ajanta Pharma Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Ajanta Pharma Ltd.

  • Ajanta Pharma Continues Upward Trend - 04 Jul, 2025

    Ajanta Pharma Ltd gained 1.6% on July 4, 2025, marking its third consecutive session of increases. The stock is up 17.95% over the past year, outperforming both NIFTY and the Nifty Pharma index. Despite a slight decline in benchmark indices, Ajanta Pharma shows strong performance with a 3.71% rise in the last month.
  • Ajanta Pharma Reports Strong Financial Growth - 12 Jun, 2025

    Ajanta Pharma's consolidated financials show significant growth, with Q4 revenue at Rs 1,909.74 Crores and net profit at Rs 319.00 Crores. The annual revenue rose to Rs 7,028.46 Crores, reflecting a positive trend.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.17K Cr → 1.18K Cr (in ₹), with an average increase of 1.0% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, AJANTPHARM stock has moved up by 4.7%

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.89% to 15.13% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 132.9% return, outperforming this stock by 11.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.26% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 49.2% return, outperforming this stock by 30.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 7.45% to 7.39% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 9.26% to 8.86% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 232.88 Cr → 225.26 Cr (in ₹), with an average decrease of 3.3% per quarter

About Ajanta Pharma Ltd

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Revenue: ₹1,170.41Cr as on March 2025 (Q4 FY25)
Net Profit: ₹225.26Cr as on March 2025 (Q4 FY25)
Listing date: 29 May, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
IndustryPharmaceuticals
CEOMannalal B Agrawal
E-voting on sharesClick here to vote

Mutual Funds that own Ajanta Pharma Ltd

Check out the Mutual Funds with significant holdings in Ajanta Pharma Ltd.

FAQs

What is Ajanta Pharma Ltd share price today?

Ajanta Pharma Ltd share price today stands at ₹2695.5, Open: ₹2645, Previous Close: ₹2631.5, High: ₹2710, Low: ₹2623.2, 52 Week High: ₹3485, 52 Week Low: ₹2160.15.

What is today's traded volume of Ajanta Pharma Ltd?

Today's traded volume of Ajanta Pharma Ltd is 2.41L. Which means that 2.41L shares of Ajanta Pharma Ltd were bought and sold on the stock market during today's trading session.

What is Ajanta Pharma Ltd's market cap today?

Today's market capitalisation of Ajanta Pharma Ltd is ₹33,670.06 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Ajanta Pharma Ltd?

Ajanta Pharma Ltd’s 52 week high is ₹3485 and 52 week low is ₹2160.15. The current share price of Ajanta Pharma Ltd is ₹2695.5, which is -22.65% down from its 52 week high and 24.78% up from its 52 week low.